Skip to main content

RENAISSANCE TECHNOLOGIES LLC

Position in NVO — Novo Nordisk A S

CIK 1037389 NEW YORK, NY

Position in NVO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$145,374,262
+$20,530,066 QoQ
Shares Held
3,032,421
-10.7% QoQ
Ownership
0.069%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#26
of 1,348 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NVO Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

RENAISSANCE TECHNOLOGIES LLC holds $598,181,374 across 8 Drug Manufacturers - General names. NVO ranks #2 (24.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NVO
Novo Nordisk A S
This page
3,032,421 $145,374,262

All Filings in NVO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $145,374,262 3,032,421
2026-03-31 $124,844,196 3,397,121
2025-12-31 $161,985,536 3,183,678
2025-09-30 $159,921,958 2,881,996
2025-06-30 $340,737,659 4,936,796
2025-03-31 $473,677,738 6,821,396
2024-12-31 $715,083,915 8,312,996
2024-09-30 $975,101,737 8,189,315
2024-06-30 $1,308,265,484 9,165,374
2024-03-31 $1,384,931,901 10,786,074
2023-12-31 $1,432,713,705 13,849,335
2023-09-30 $1,475,908,547 16,229,476
2023-06-30 $1,516,506,988 9,370,988
2023-03-31 $1,719,076,112 10,802,288
2022-12-31 $1,705,864,337 12,604,288
2022-09-30 $1,525,222,817 15,308,871
2022-06-30 $1,953,331,239 17,529,671
2022-03-31 $2,041,539,979 18,383,971
2021-12-31 $2,141,089,552 19,116,871
2021-09-30 $2,077,720,822 21,640,671
2021-06-30 $2,025,648,317 24,181,071
2021-03-31 $1,675,162,558 24,846,671
2020-12-31 $1,874,855,794 26,841,171
2020-09-30 $1,952,457,068 28,121,231
2020-06-30 $1,879,919,733 28,709,831
2020-03-31 $1,677,185,605 27,860,226